United Therapeutics’ founding objective to manufacture artificial organs and overcome the critical shortage of human organs for transplantation is nearing takeoff, laying the foundations for its plans to operate a fleet of zero-emission, optionally piloted vertical-flight aircraft to transport...
Subscription Required
United Therapeutics’ Work Underlines Need For eVTOL Organ Transport is published in Advanced Air Mobility Report, an Aviation Week Intelligence Network (AWIN) Market Briefing and is included with your AWIN Premium membership.
Already a member of AWIN or subscribe to Advanced Air Mobility through your company? Login with your existing email and password
Not a member? Learn how to access the market intelligence and data you need to stay abreast of what's happening in the air transport community.